SELLAS Life Sciences Group Files Q1 2025 10-Q
Ticker: SLS · Form: 10-Q · Filed: May 13, 2025 · CIK: 1390478
| Field | Detail |
|---|---|
| Company | Sellas Life Sciences Group, Inc. (SLS) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
SELLAS Life Sciences Group filed their Q1 2025 10-Q. Address: 7 Times Square, NY.
AI Summary
SELLAS Life Sciences Group, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Galena Biopharma, Inc. and RXi Pharmaceuticals Corp, is focused on pharmaceutical preparations. Their business address is located at 7 Times Square, Suite 2503, New York, NY 10036.
Why It Matters
This filing provides investors with an update on the financial health and operational status of SELLAS Life Sciences Group for the first quarter of 2025.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report with no immediately apparent significant financial distress or major operational changes.
Key Players & Entities
- SELLAS Life Sciences Group, Inc. (company) — Filer of the 10-Q report
- Galena Biopharma, Inc. (company) — Former company name
- RXi Pharmaceuticals Corp (company) — Former company name
- 7 Times Square, Suite 2503, New York, NY 10036 (location) — Business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
What was SELLAS Life Sciences Group previously known as?
The company was formerly known as Galena Biopharma, Inc. and RXi Pharmaceuticals Corp.
What is the business address of SELLAS Life Sciences Group?
The business address is 7 Times Square, Suite 2503, New York, NY 10036.
What is the Standard Industrial Classification (SIC) code for SELLAS Life Sciences Group?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was the company's name last changed?
The company's name was last changed from RXi Pharmaceuticals Corp on 20110926 and from GALENA BIOPHARMA, INC. on 20110922.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding SELLAS Life Sciences Group, Inc. (SLS).